Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult Hodgkin lymphoma patient
- 5 April 2011
- journal article
- Published by SAGE Publications in Therapeutic Advances in Hematology
- Vol. 2 (2) , 111-119
Abstract
There have been an increasing number of survivors of successful treatment of Hodgkin lymphoma (HL) over the past 30 years. Although these survivors may be cured of their HL, long-term morbidity and mortality are associated with late toxicities of treatment. Identification of these late complications will lead to strategies to manage them when they occur and hopefully to decrease the risk of their development. Second malignancies followed by cardiovascular disease are the leading causes of late morbidity and mortality. Musculoskeletal difficulties, endocrine abnormalities including sterility and thyroid disease, heart and lung damage, persistent fatigue and psychosocial distress have also been seen. The subjects of this review are the late complications of primary treatment of HL and autologous stem cell transplantation, usually for relapsed disease.Keywords
This publication has 64 references indexed in Scilit:
- Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapyBritish Journal of Cancer, 2010
- Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trialThe Lancet Oncology, 2009
- Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trialsHaematologica, 2009
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 StudyJournal of Clinical Oncology, 2009
- Late Effects in Survivors of Hodgkin and Non-Hodgkin Lymphoma Treated with Autologous Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor StudyTransplantation and Cellular Therapy, 2007
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Cognitive‐behavioral management of chemotherapy‐related cognitive changePsycho-Oncology, 2006
- Better quality of life among 10–15 year survivors of Hodgkin’s lymphoma compared to 5–9 year survivors: A population-based studyEuropean Journal of Cancer, 2006
- Quality of life in long-term Hodgkin’s disease survivors with chronic fatigueEuropean Journal of Cancer, 2006
- Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 PatientsJNCI: Journal of the National Cancer Institute, 2006